Tuesday, August 19, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

NetApp Inc Exceeds Expectations with Strong ThirdQuarter Results and Positive Analyst Outlook

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Fiances and technology
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

NetApp, Inc. (NASDAQ: NTAP) exceeded market expectations with its strong third-quarter financial results, reporting adjusted earnings per share of $1.94 and quarterly sales of $1.61 billion. Looking ahead to the fourth quarter, NetApp anticipates adjusted earnings between $1.73 to $1.83 per share and net revenues ranging from $1.585 billion to $1.735 billion.

Barclays, Evercore ISI Group, and TD Cowen all raised NetApp’s price targets, reflecting confidence in the company’s growth prospects. The average 12-month price target for NetApp is $89.93, with a high forecast of $105.00 and a low forecast of $73.00. Analyst consensus rates NetApp as a Hold based on ratings from 16 Wall Street analysts.

Following NetApp’s positive financial performance, analysts have adjusted their price targets upwards, reaffirming confidence in the company’s market position and future growth potential.

NTAP Stock Shows Strong Performance on March 1, 2024: Potential for Further Growth

On March 1, 2024, NTAP stock showed strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been experiencing positive price momentum and may continue to see upward movement in the near future.

The price of NTAP shares increased by $1.09 since the market last closed, representing a 1.24% rise from the previous closing price of $89.12. Additionally, in pre-market trading, the stock rose by $16.78, further demonstrating the bullish sentiment surrounding NTAP on that day.

Investors may be drawn to NTAP due to its strong price performance and potential for further growth. Trading near the top of its 52-week range suggests that the stock has been performing well compared to its historical prices, which could attract more buyers looking to capitalize on the positive momentum.

Overall, NTAP’s strong performance on March 1, 2024, indicates that the stock may be worth considering for investors looking for opportunities in the market. However, as with any investment, it is crucial to carefully assess the risks and potential rewards before making a decision.

NetApp Inc. (NTAP) Stock Shows Strong Performance with Impressive Financial Results

On March 1, 2024, NetApp Inc. (NTAP) stock showed strong performance based on its recent financial results. According to data from CNN Money, the company reported total revenue of $6.36 billion for the past year, which remained flat compared to the previous year. However, there was an 8.94% increase in total revenue since the last quarter, reaching $1.56 billion.

Net income for NetApp Inc. was reported at $1.27 billion for the past year, showing a significant increase of 35.97% compared to the previous year. The net income also increased by 56.38% since the last quarter, reaching $233.00 million.

Earnings per share (EPS) for NetApp Inc. stood at $5.79 for the past year, reflecting a 41.53% increase from the previous year. The EPS also increased by 60.09% since the last quarter, reaching $1.10.

Overall, these financial results indicate a strong performance for NetApp Inc. on March 1, 2024. Investors and analysts may view these results as a signal of strong financial health and growth potential for NetApp Inc. Moving forward, it will be important to monitor the company’s performance to see if it can sustain this positive momentum in the coming quarters.

Tags: NTAP
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Bull Market

Analyst Maintains Positive Outlook on Endava with Adjusted Price Target

Ai Sleeping

Sleep Quality's Impact on Physical and Financial Well-Being

DVY stock news

Truist Securities Analyst Reiterates Hold Recommendation on Best Buy Co

Recommended

FLO stock news

Visa Reports Impressive Financial Performance in Q1 2024

2 years ago
Finance_Banking (2)

Amerant Bank Announces Asset Sale Agreement with Prime Finance Advisor

2 years ago

Adial Pharmaceuticals Expands Scope of Genetic Diagnostic Technology for Addiction Treatment

2 years ago
Finance_Commercial

Wells Fargo Upgrades Price Target for CrowdStrike Holdings Expresses Bullish Stance

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Sabra Health Care REIT Demonstrates Resilience with Strong Quarterly Performance

IBM’s Strategic Crossroads: Major Indian Contract Contrasts With AI Security Concerns

Institutional Investors Show Diverging Views on Dish Network’s Future

Institutional Investors Back Rush Enterprises B Despite Earnings Shortfall

Rocket Lab’s Next Mission Sets Stage for Potential Stock Rebound

Navigating Regulatory Crosscurrents: The Shifting Tides for Global Shipping

Trending

Viridian Therapeutics Stock
Stocks

Viridian Therapeutics Faces Financial Crossroads Amid Promising Drug Development

by Dieter Jaworski
August 19, 2025
0

The biotech firm Viridian Therapeutics finds itself at a pivotal financial juncture as it balances promising clinical...

Tilray Stock

Tilray Stock: Regulatory Optimism Meets Market Realities

August 19, 2025
Murphy Oil Stock

Major Investors Divided on Murphy Oil’s Prospects

August 19, 2025
Sabra Health Care Reit Stock

Sabra Health Care REIT Demonstrates Resilience with Strong Quarterly Performance

August 19, 2025
IBM Stock

IBM’s Strategic Crossroads: Major Indian Contract Contrasts With AI Security Concerns

August 19, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Viridian Therapeutics Faces Financial Crossroads Amid Promising Drug Development August 19, 2025
  • Tilray Stock: Regulatory Optimism Meets Market Realities August 19, 2025
  • Major Investors Divided on Murphy Oil’s Prospects August 19, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Index
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com